Considerations for Diabetes Translational Research in Real-World Settings-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Considerations for Diabetes Translational Research in Real-World Settings

Published:2003-09-01 Issue:9 Volume:26 Page:2670-2674
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Garfield Sanford A.¹,Malozowski Saul¹,Chin Marshall H.²,Venkat Narayan K.M.³,Glasgow Russell E.⁴,Green Lawrence W.³,Hiss Roland G.⁵,Krumholz Harlan M.⁶,

Affiliation:

1. Division of Endocrinological and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland

2. Department of Medicine, University of Chicago, Chicago, Illinois

3. Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia

4. Clinical Research Unit, Kaiser Permanente, Canon City, Colorado

5. Department of Medical Education, University of Michigan, Ann Arbor, Michigan

6. Department of Medicine, Yale School of Medicine, New Haven, Connecticut

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/26/9/2670/665178/dc0903002670.pdf

Reference45 articles.

1. Spiegel A: Opening remarks. Diabetes Mellitus Interagency Coordinating Committee Translation Conference Washington, D.C., 27 September 2002

2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986, 1993

3. UK Prospective Diabetes Study Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837–853, 1998

4. UK Prospective Diabetes Study Group: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 317: 713–720, 1998

5. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393–403, 2002

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing Awareness and Utilization of Preventive Services, Complications, and Risk Factors Among Diabetic Patients in Jeddah, Saudi Arabia;Pakistan Journal of Health Sciences;2023-06-30

2. Diabetes Management in the United States;The Diabetes Textbook;2023

3. Provider–Patient Interactions as Predictors of Lifestyle Behaviors Related to the Prevention and Management of Diabetes;Diabetology;2022-03-01

4. Adopting and implementing an innovative model to organize diabetes care within First Nations communities: A qualitative assessment;BMC Health Services Research;2021-05-03

5. Cost-effectiveness of a Stepwise Approach vs Standard Care for Diabetes Prevention in India;JAMA Network Open;2020-07-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3